Form 4: Surmodics SVP, Teri Woodwick Sides, Reports Stock Transaction

Teri Woodwick Sides, SVP at Surmodics, disposed of 946 shares of common stock to cover tax obligations.

Summary

• Teri Woodwick Sides, a Senior Vice President at Surmodics, filed a Form 4 indicating a transaction involving the company's common stock.
• On December 4, 2024, Ms. Sides disposed of 946 shares of Surmodics common stock.
• The shares were disposed of at a price of $39.91 per share.
• This transaction was to cover tax obligations related to vesting of restricted stock units.
• Following the transaction, Ms. Sides directly owns 34,703 shares of Surmodics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction by a company executive, which is neither positive nor negative for the company's outlook.

Industry Context

Form 4 filings are a routine part of corporate governance and provide transparency into the transactions of company insiders. This filing is typical for executives who receive stock-based compensation.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider activity.
• Similar filings are made by executives at comparable medical device companies such as Medtronic, Boston Scientific, and Abbott, when they sell shares.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale of shares by an executive.

Key Dates

Keywords

Surmodics, SRDX, Form 4, Teri Woodwick Sides, stock transaction, insider trading, beneficial ownership, SEC filing